Specificity Of Hematomas Following Vacuum-Assisted Biopsy (VAB)

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

Vacuum-assisted biopsy (VAB), the current gold standard for minimally invasive breast diagnosis, enables multi-sample acquisition per insertion. However, its defining negative pressure mechanism, while boosting efficiency, significantly influences postoperative hematoma formation. Understanding the pathogenesis of VAB-related hematomas is vital for protocol optimization.

VAB systems utilize side-port negative pressure (typically -60 kPa to -80 kPa, equivalent to 60%–80% atmospheric pressure) to draw tissue into a cutting chamber for rotational excision. This high suction induces two vascular injury mechanisms: direct effects, where strong suction draws adherent vessels into the cutting groove, tearing walls; and indirect effects, where localized vasodilation improves visualization but elevates puncture risks. Clinically, 70% of hematomas emerging within 24 hours post-VAB correlate directly with negative pressure application.

Compared to conventional core needle biopsy, VAB hematomas exhibit three distinct features: earlier onset (immediate to 2 hours post-procedure); regular morphology (often round/oval, mirroring the cavity shape); and slower resolution (averaging 14–21 days vs. 7–10 days for standard biopsies). Larger tissue defects create "residual cavities" prone to blood pooling; insufficient postoperative compression permits continuous oozing to fill these spaces.

To mitigate VAB-related hematomas, three key measures are advised: Pressure modulation: Initiate suction at lower levels (-40 kPa) during insertion until vessels are avoided, then escalate to working pressure. Progressive withdrawal: Maintain negative pressure while slowly retracting the needle post-biopsy to aspirate tract seepage. Cavity management: For lesions >2 cm deep, instill hemostatic gels or place absorbable hemostatic gauze before withdrawal. Notably, novel VAB devices with "intelligent pressure control systems" automatically adjust suction based on real-time tissue tension monitoring, reducing hematoma incidence by 42%. Future integration of contrast-enhanced ultrasound to map vascular pathways will further refine precision and minimize invasiveness.